person · Reporting owner
Lynton Nicholas Hollmeyer
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cardlytics, Inc.
Report date July 01, 2026 · Filed July 06, 2026
Section 16 reporting ended · disclosed 2026-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,942 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Exercise / conversion · Acquired 157 · Balance 16,942 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. |
| Common StockSEC Table I · non-derivative | Direct | 18,442 |
Reported balance
After 2026-07-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-07-01 · Exercise / conversion · Acquired 1,500 · Balance 18,442 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 18,754 |
Reported balance
After 2026-07-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-07-01 · Exercise / conversion · Acquired 312 · Balance 18,754 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 21,504 |
Reported balance
After 2026-07-01 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-07-01 · Exercise / conversion · Acquired 2,750 · Balance 21,504 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 19,353 |
Reported balance
After 2026-07-02 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-07-02 · Sale · Disposed 2,151 · Balance 19,353 F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). F3: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-07-01 · Exercise / conversion · Disposed 157 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F5: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,500 |
Reported balance
After 2026-07-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-01 · Exercise / conversion · Disposed 1,500 · Balance 4,500 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 938 |
Reported balance
After 2026-07-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-07-01 · Exercise / conversion · Disposed 312 · Balance 938 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 19,250 |
Reported balance
After 2026-07-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-07-01 · Exercise / conversion · Disposed 2,750 · Balance 19,250 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. F7: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
F3: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2026. The Reporting Person did not sell shares for any other purpose.
F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F5: 25% of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
F6: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
F7: RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000017 · wk-form4_1704329973.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 47 | $16.35 | $768.45 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 8 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,310 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,101 | $15.70 | $32,985.70 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,357 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,703 | $14.92 | $55,248.76 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,458 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 6,900 | $13.55 | $93,495.00 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,161 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · derivative · entry 12 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,358 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F9 · derivative.exercise_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F9 · derivative.expiration_date: This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · derivative · entry 11 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,812 Underlying: Common Stock · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F8 · derivative.exercise_date: This RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F8 · derivative.expiration_date: This RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · derivative · entry 10 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 415 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F7 · derivative.exercise_date: This RSU award was originally for 830 shares. Fifty percent (50%) of the shares under this award vested on October 1, 2022, and fifty percent (50%) of this award vested on October 1, 2023. F7 · derivative.expiration_date: This RSU award was originally for 830 shares. Fifty percent (50%) of the shares under this award vested on October 1, 2022, and fifty percent (50%) of this award vested on October 1, 2023. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · derivative · entry 9 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F6 · derivative.exercise_date: This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. F6 · derivative.expiration_date: This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 415 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 22:27 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-23-000139 · wk-form4_1696372056.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:45 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 7,500 | $13.67 | $102,525.00 |
DisclosureSEC source: 0001666071-23-000107 · wk-form4_1691613917.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,486 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.66 to $13.77, inclusive. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 20:45 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 165 | $14.05 | $2,318.25 |
DisclosureSEC source: 0001666071-23-000107 · wk-form4_1691613917.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,986 F1 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on April 1, 2023, April 2, 2023 and April 20, 2023. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.11, inclusive. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 20:45 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 4,957 | $13.48 | $66,820.36 |
DisclosureSEC source: 0001666071-23-000107 · wk-form4_1691613917.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,151 F1 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on April 1, 2023, April 2, 2023 and April 20, 2023. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 9,906 | $6.13 | $60,684.16 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · nonDerivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,108 F2 · shares: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 1, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 6,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · derivative · entry 7 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,936 Underlying: Common Stock · 6,311 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F10 · derivative.exercise_date: Twenty-five percent (25%) of the shares under this award vest on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F10 · derivative.expiration_date: Twenty-five percent (25%) of the shares under this award vest on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F7 · balance_after: This number of RSUs granted was previously incorrectly reported this represents the correct number of RSUs remaining. F8 · balance_after: This grant was previously incorrectly reported as a performance stock unit. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,394 Underlying: Common Stock · 581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares under this award vest on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F6 · derivative.expiration_date: Twenty-five percent (25%) of the shares under this award vest on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F7 · balance_after: This number of RSUs granted was previously incorrectly reported this represents the correct number of RSUs remaining. F8 · balance_after: This grant was previously incorrectly reported as a performance stock unit. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: 25% of the RSUs shall vest on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. F5 · derivative.expiration_date: 25% of the RSUs shall vest on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000085 · wk-form4_1688600904.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 20, 2023 Filed Apr 20, 2023 20:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024978 · doc4.xml · derivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,364 Underlying: Common Stock · 682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: This RSU grant vests 25% over 4 years equally on each grant anniversary. 25% of the shares vested on April 20, 2022, 25% of the shares vested on April 20, 2023, and the remaining unvested shares will vest on April 20, 2024 and April 20, 2025, equally, provided the Reporting Person continuously provides service to the Issuer through the vesting dates. F2 · derivative.expiration_date: This RSU grant vests 25% over 4 years equally on each grant anniversary. 25% of the shares vested on April 20, 2022, 25% of the shares vested on April 20, 2023, and the remaining unvested shares will vest on April 20, 2024 and April 20, 2025, equally, provided the Reporting Person continuously provides service to the Issuer through the vesting dates. Read SEC document |
| April 20, 2023 Filed Apr 20, 2023 20:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024978 · doc4.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2023 Filed Apr 12, 2023 21:29 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000061 · wf-form4_168133495465978.xml · derivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: 25% of the RSUs shall vest on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. F2 · derivative.expiration_date: 25% of the RSUs shall vest on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. Read SEC document |
| April 02, 2023 Filed Apr 4, 2023 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000047 · wf-form4_168063881527605.xml · derivative · entry 6 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The shares under this award vest in full on April 2, 2023, provided the Reporting Person continuously provides service to the Issuer through the vesting date. F4 · derivative.expiration_date: The shares under this award vest in full on April 2, 2023, provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| April 02, 2023 Filed Apr 4, 2023 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000047 · wf-form4_168063881527605.xml · nonDerivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 2,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000047 · wf-form4_168063881527605.xml · derivative · entry 5 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,988 Underlying: Common Stock · 2,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000047 · wf-form4_168063881527605.xml · derivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807 Underlying: Common Stock · 806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 2,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000047 · wf-form4_168063881527605.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:07 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000047 · wf-form4_168063881527605.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 01, 2023 Filed Jul 7, 2023 20:19 UTC Amendment | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 2,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041792 · doc4a.xml · derivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,975 Underlying: Common Stock · 2,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares under this award vest on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F3 · derivative.exercise_date: The initial Form 4 misreported the vesting schedule of this RSU award. This represents the correct vesting schedule. F2 · derivative.expiration_date: Twenty-five percent (25%) of the shares under this award vest on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. F3 · derivative.expiration_date: The initial Form 4 misreported the vesting schedule of this RSU award. This represents the correct vesting schedule. F4 · balance_after: The initial Form 4 misreported the number of securities beneficially owned after the transaction. This represents the correct number of securities beneficially owned after the transaction. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 21:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 6,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000001 · wf-form4_167364411425264.xml · derivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. F3 · derivative.expiration_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 21:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 6,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000001 · wf-form4_167364411425264.xml · derivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,312 Underlying: Common Stock · 6,312 shares Expires not disclosed F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. F3 · derivative.expiration_date: On January 12, 2023 the Compensation Committee of the Issuer's Board of Directors certified that a certain milestone had been achieved related to the installation of our Ad Server at a certain FI Partner, resulting in the vesting of this award. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 21:08 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000001 · wf-form4_167364411425264.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 22:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000158 · wf-form4_167097062284883.xml · derivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 12 months after the Certification. F2 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 12 months after the Certification. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 22:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000158 · wf-form4_167097062284883.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2022 Filed Nov 8, 2022 21:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 24 | $3.98 | $95.46 |
DisclosureSEC source: 0001666071-22-000139 · wf-form4_166794411961710.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,124 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:59 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1 | $3.92 | $3.92 |
DisclosureSEC source: 0001666071-22-000145 · wf-form4_166811756321115.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,123 F1 · kind: Share sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 509 | $4.34 | $2,210.43 |
DisclosureSEC source: 0001666071-22-000139 · wf-form4_166794411961710.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,148 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2022. Read SEC document |
| October 06, 2022 Filed Nov 3, 2022 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000135 · wf-form4_166750620235736.xml · derivative · entry 4 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification. F4 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification. Read SEC document |
| October 06, 2022 Filed Nov 3, 2022 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000135 · wf-form4_166750620235736.xml · nonDerivative · entry 2 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| October 01, 2022 Filed Nov 3, 2022 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000135 · wf-form4_166750620235736.xml · derivative · entry 3 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415 Underlying: Common Stock · 415 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: Fifty percent (50%) of the shares under this award vested on October 1, 2022, and fifty percent (50%) of this award vest on October 1, 2023, provided the Reporting Person continuously provides service to the Issuer through the vesting date. F3 · derivative.expiration_date: Fifty percent (50%) of the shares under this award vested on October 1, 2022, and fifty percent (50%) of this award vest on October 1, 2023, provided the Reporting Person continuously provides service to the Issuer through the vesting date. Read SEC document |
| October 01, 2022 Filed Nov 3, 2022 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000135 · wf-form4_166750620235736.xml · nonDerivative · entry 1 Lynton Nicholas Hollmeyer · CIK 0001941467 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.